[Non-ST acute coronary syndromes]
J Ph Collet1, R Choussat, G Montalescot
1Institut de cardiologie, groupe hospitalier La Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris.
Insights
Acute coronary syndromes, a leading cause of death, are effectively managed with combined antithrombotic therapy. This strategy reduces major coronary events and enhances early invasive interventions, improving patient outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Context:
- Acute coronary syndromes (ACS) represent the primary cause of mortality in France.
- Unstable angina is the most prevalent form of ACS.
- Effective risk stratification is crucial for predicting patient outcomes and hemorrhage risk.
Purpose:
- To evaluate the efficacy and safety of combined antithrombotic therapy in managing acute coronary syndromes.
- To assess the impact of this therapy on major coronary events and major hemorrhage.
- To determine the role of combined antithrombotic therapy in conjunction with early invasive strategies.
Summary:
- Combined antithrombotic therapy, including aspirin, clopidogrel, and low-molecular-weight heparin (LMWH), significantly reduces major coronary events.
- This aggressive therapeutic approach is well-tolerated when administered for a short duration.
- The use of combined antithrombotic therapy enhances the benefits of early invasive strategies, such as coronary angiography and stent percutaneous coronary intervention.
Impact:
- The findings support the use of combined antithrombotic therapy as a cornerstone in the management of ACS.
- This strategy improves patient prognosis by reducing morbimortality associated with ACS.
- It facilitates the successful implementation of early revascularization procedures, leading to better long-term outcomes.
Abstract:
Acute coronary syndromes are the first cause of death in France. Unstable angina is the most frequent acute coronary syndrome. Risk stratification to predict morbimortality and the risk of major hemorrhage is the key step of the medical approach. Combined antithrombotic therapy (aspirine + clopidogrel + LMWH) has led to a substantial reduction of major coronary events with a good tolerance because of the short duration of such aggressive strategy. This combined antithrombotic also allowed to increase the benefit of an early invasive strategy including coronary angiogram with stent percutaneous coronary intervention.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification

